» Articles » PMID: 29630784

Proton Therapy for Central Nervous System Tumors in Children

Overview
Date 2018 Apr 10
PMID 29630784
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Proton therapy is a form of particle therapy with physical properties that provide a superior dose distribution compared to photons. The ability to spare healthy, developing tissues from low dose radiation with proton therapy is well known. The capability to decrease radiation exposure for children has been lauded as an important advance in pediatric cancer care, particularly for central nervous system (CNS) tumors. Favorable clinical outcomes have been reported and justify the increased cost and burden of this therapy. In this review, we summarize the current literature for proton therapy for pediatric CNS malignancies, with a focus on clinical outcomes to date.

Citing Articles

The comparison of acute toxicities associated with craniospinal irradiation between photon beam therapy and proton beam therapy in children with brain tumors.

Uemura S, Demizu Y, Hasegawa D, Fujikawa T, Inoue S, Nishimura A Cancer Med. 2022; 11(6):1502-1510.

PMID: 35137555 PMC: 8921900. DOI: 10.1002/cam4.4553.


Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: Survival analysis and impact of salvage re-irradiation.

de Rezende A, Weltman E, Chen M, Helito J, de Carvalho I, Sakuraba R PLoS One. 2019; 14(12):e0226350.

PMID: 31860688 PMC: 6924640. DOI: 10.1371/journal.pone.0226350.


Effects of Radiation Therapy on Neural Stem Cells.

Michaelidesova A, Konirova J, Bartunek P, Zikova M Genes (Basel). 2019; 10(9).

PMID: 31450566 PMC: 6770913. DOI: 10.3390/genes10090640.


Role of Radiation Therapy in the Management of Diffuse Intrinsic Pontine Glioma: A Systematic Review.

Gallitto M, Lazarev S, Wasserman I, Stafford J, Wolden S, Terezakis S Adv Radiat Oncol. 2019; 4(3):520-531.

PMID: 31360809 PMC: 6639749. DOI: 10.1016/j.adro.2019.03.009.


Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma.

Tensaouti F, Ducassou A, Chaltiel L, Bolle S, Habrand J, Alapetite C Front Oncol. 2019; 9:531.

PMID: 31293971 PMC: 6598548. DOI: 10.3389/fonc.2019.00531.